Inventor
ZHANG NINGYAN
US23 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG NINGYAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV TEXAS
18 patentsUS12202895B2Jan 21, 2025
LILRB4 antibodies and uses thereof
UNIV TEXAS2 citations73
US10875912B2Dec 29, 2020
EGFL6 specific monoclonal antibodies and methods of their use
UNIV TEXAS2 citations72
US10358501B2Jul 23, 2019
HER3 specific monoclonal antibodies for diagnostic and therapeutic use
UNIV TEXAS2 citations72
US9725520B2Aug 8, 2017
HER3 specific monoclonal antibodies for diagnostic and therapeutic use
UNIV TEXAS4 citations72
US11912758B2Feb 27, 2024
Methods of treating metastasis, including inhibiting bone cancer metastasis, by administering an antibody which binds connexin 43 (Cx43) hemichannel
UNIV TEXAS1 citations70
US10889637B2Jan 12, 2021
Methods of treating an osteolytic tumor and spinal cord injury by administering connexin (Cx) 43 hemichannel-binding antibodies
UNIV TEXAS2 citations70
US10501538B2Dec 10, 2019
Anti-LILRB antibodies and their use in detecting and treating cancer
UNIV TEXAS5 citations70
US12152071B2Nov 26, 2024
EGFL6 specific monoclonal antibodies and methods of their use
UNIV TEXAS0 citations62
US11174320B2Nov 16, 2021
HER3 specific monoclonal antibodies for diagnostic and therapeutic use
UNIV TEXAS0 citations62
US12503500B2Dec 23, 2025
Connexin 43 (Cx43) hemichannel-binding antibodies
UNIV TEXAS0 citations60
US11906519B2Feb 20, 2024
Methods for identifying LILRB-blocking antibodies
UNIV TEXAS0 citations60
US11498963B2Nov 15, 2022
Anti-LILRB antibodies and their use in detecting and treating cancer
UNIV TEXAS0 citations60
US11377491B2Jul 5, 2022
Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer
UNIV TEXAS1 citations60
US12037390B2Jul 16, 2024
Leptin antibodies and method of reducing leptin
UNIV TEXAS0 citations59
US11760799B2Sep 19, 2023
Leptin antibodies
UNIV TEXAS0 citations59
US12331110B2Jun 17, 2025
Monoclonal antibodies against endotrophin and the use thereof
UNIV TEXAS0 citations57
US12570710B2Mar 10, 2026
Targeting LILRB4 with CAR-T or CAR-NK cells in the treatment of cancer
UNIV TEXAS0 citations56
US12331130B2Jun 17, 2025
DDR1 antibodies and uses thereof
UNIV TEXAS0 citations47